Jnana Therapeutics

Jnana Therapeutics is a biotechnology company leveraging a next-generation chemoproteomics platform to address challenging drug targets, including metabolite transporters from the solute carrier (SLC) family. Jnana focuses on developing first-in-class therapies for various diseases, including immune-mediated, neurological, and metabolite-dependent conditions. Headquartered in Boston, Jnana was founded by world-renowned scientists and is supported by leading life science investors.